Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chin J et al. – Tamoxifen is commonly used by women to reduce the risk of breast cancer recurrence. Tamoxifen can also cause abnormal changes to the lining of the womb (endometrium), including polyps and cancer...The Mirena LNG–IUS appears to prevent the development of benign endometrial polyps in breast cancer patients taking tamoxifen, over a one–year period. There is no clear evidence from the available randomised controlled trials that LNG–IUS prevents endometrial hyperplasia or adenocarcinoma in these patients. Larger studies are necessary to assess the effects of LNG–IUS in preventing endometrial hyperplasia and endometrial cancer, and to determine whether LNG–IUS might have an impact on the risk of breast cancer recurrence.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address